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INTRODUCTION
Chest wall primary malignant tumors are among the
rarest cartilaginous tumors, accounting for 8% of cases1.
Additionally, the chest wall is not the most common site for
chondrosarcomas (15% of chondrosarcoma cases)2. One can
reasonably conclude that this lack of cases is responsible for
the scarcity of studies on thoracic chondrosarcomas.
The optimal treatment for this tumor has not improved
over time; radical surgery remains the only curative option.
There is no effective chemotherapy, and the tumor is
relatively radio-insensitive. Therefore, the pursuit of wide-
margin resections often leads to the need for complex chest
wall reconstruction techniques.
Even though this series addresses a small sample of
patients, it includes a considerable number of tumors that
were surgically challenging due to their large size and/or
anatomically unfavorable locations for performance of
wide-margin resections.
Case Reports
A total of eleven patients were selected for the study. The
series consisted of eight males (72.7%) and three (27.3%)
females with a mean age of 51.5 years (range: 24 to 74 years).
Eight (72.7%) of the tumors were located in the ribs, and
three (27.3%) were in the sternum. Chest computed
tomography (CT) scans were used to diagnose the tumor
size, its extension to the ribs and sternum and its extension
to vessels beyond pleuropulmonary dissemination. The
main surgical aspects of the study are summarized in
Table 1. All patients had a primary chondrosarcoma and
underwent curative surgery. The mean follow-up time was
63 months (range: 15 to 167).
Only three (27.3%) patients noticed a palpable asympto-
matic thoracic mass. Eight pre-operative biopsies were
performed in 7 (63.6%) cases (cases: 1, 2, 3, 6, 7, 10 and
11). A cartilaginous malignant neoplasm was reported in 7
biopsies.
Rib resection was performed in 8 of the cases (mean: 2.5
ribs, range: 1 to 4) and a subtotal sternectomy in 3. The mean
tumor size was 10.66 cm (4 to 21 cm), measured by the
largest diameter. Reconstruction techniques included the
use of Marlex mesh for 10 cases (90.9%) and a muscle flap
for 5 (45.4%) (isolated pectoralis major in 3, rectus abdominis
and latissimus dorsi in 1 and rectus abdominis, pectoralis major
and pectoralis minor in 1). There was one case in which an
isolated pectoralis major muscle flap was used during
surgery for local recurrence. The surgical margins were
intralesional (defined as positive microscopic margins) in 5
patients (45.4%), wide (defined as 4 cm of healthy tissue
surrounding the tumor margin) in 4 (36.4%) and marginal
(defined as microscopically free from tumor but less than
4 cm from the tumor margin) in 2 (18.2%). High-grade
tumors (GIII) were observed in 2 patients (18.2%), inter-
mediate-grade tumors in 8 (72.7%) and low-grade tumors
(GI) in 1 (9.1%). The average duration of postoperative
hospital stay was 8.81 days (range: 2 to 32).
Four patients are currently alive with no evidence of
disease (NED) (cases 8 through 11). There was one
perioperative death (case 3), and three patients died due
to metastatic disease (cases 1, 4 and 7). It was not possible to
retrieve data about the postoperative course for three
patients (cases 2, 5 and 6).
Regarding the perioperative death (case 3), the patient
developed mediastinitis that was surgically treated, but the
patient died five days later due to septic shock.
Regarding the three patients who died during follow-up
(cases 1, 4 and 7), the first patient had three recurrences,
the first of which occurred nine years later. All of these
recurrences were treated surgically. Two years after the last
resection, the patient died due to metastatic disease. The
second patient (case 4) was identified as lost at the 25-month
follow-up. He was alive with NED at the last clinical
evaluation performed. The third patient (case 7) underwent
en-bloc rib resection and lung segmentectomy due to a large
grade II chondrosarcoma (20614613 cm). One year later,
she underwent lung metastasectomy and was scheduled for
adjuvant chemotherapy, but she died four months later due
to tumor recurrence.
Four patients demonstrated postoperative complications.
The complications included the following: mediastinitis
followed by death, as previously described (case 3);
abdomino-thoracic hernia with liver and bowel protrusion,
which was treated with Marlex mesh (case 4); infected
hemothorax following surgery, leading to pulmonary
decortication (case 6); and an intra-operative internal
mammary artery lesion and foreign body granuloma in
the sternal wound that was resected 15 months later (case 9).
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Tumor recurrence occurred in 4 of 7 patients (cases 1, 7, 8,
10) after excluding the cases without follow-up (cases 2, 5, 6)
and the case of perioperative death (case 3). The mean
disease-free interval until recurrence was 43.9 months (12.6
to 115.2). All of the tumors in these patients demonstrated
an intermediate degree of differentiation; the margins were
intralesional in 1 patient (case 1), marginal in 2 (cases 7 and
10) and wide in 1 (case 8). All of these patients underwent a
new surgery. Two of the patients died due to disease
progression (cases 1 and 7), whereas two of them are
currently alive without any signs of recurrence (cases 8 and
10), with a mean disease-free interval post-recurrence
surgery of 51.3 months. For all four of these cases, this
interval was 41.2 months (4.3 to 81.2). Survival is indicated
in Table 1.
DISCUSSION
In the last 10 years, only three studies have specifically
addressed chondrosarcomas of the chest wall3-5. Similar to
our study, those series addressed a homogenous group of
patients over a short period of time.3,4 However, we
acknowledge that the failure to follow-up for three patients
calls for a careful analysis of the data. In one study on
magnetic resonance (MR) and CT scan evaluations of
chondrosarcomas, 90% of the cases revealed cortical
destruction, whereas the radiographic assessment revealed
a rate of only 65%.6 Pathological fractures were evident in
36% of the radiographies, 27% of the CT scans and only 10%
of the MR images.6 We thus believe that the lack of magnetic
resonance imaging did not influence our approach toward
the patients we reported.
Histologically, chondrosarcomas have a distinctive multi-
nodular architecture. The cells are aligned in cords, and the
strands lie in a myxoid stroma. The cells have round or oval
nuclei and a deeply eosinophilic cytoplasm. Epithelioid
cells may be found as well and lead to diagnostic
difficulties. Immunohistochemically, the tumor cells exhibit
variable expression of vimentin and S100, and epithelial
membrane antigens are usually negative for keratins.7
Because the diagnosis can be facilitated by analyzing
different areas within the tumor, some clinicians prefer
excisional biopsies over incisional or needle biopsies.8
When a wide resection does not involve significant morbi-
dity, our group advocates the use of intra-operative biopsy
to define whether the lesion is malignant. A pre-operative
biopsy (excisional for masses , 5 cm, otherwise incisional
or needle) should be performed when a wide resection will
result in a complex chest wall reconstruction or a high-
morbidity operation due to the presence of a large mass.
Following this strategy, we still observed a high incidence
of pre-operative biopsies (63.6% of cases), most of them
incisional (75%), probably due to the size of the tumors.
The mean tumor size was 10.66 cm, whereas other series
reported 8 cm.5
Intralesional and marginal margins have been identified
as risk factors for local recurrence; the hazard ratios are 28.1
and 12.2, respectively, when compared with wide margins,
according to Widhe et al.5 In the present study, we observed
a high incidence of intralesional margins (45.4%) and low
incidences of marginal (18.2%) and wide (36.4%) margins.
We consequently observed a higher recurrence rate com-
pared to other series2-5 and assumed that this discrepancyT
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might be due to the presence of large masses (the mean size
observed in this study was 10.66 cm) in difficult-to-
reconstruct locations. In fact, among the patients treated
with curative intent and non-wide margins, 3 of 7 had
tumors located in the sternum, and the remaining cases
involved procedures with relatively high morbidity and
mortality, such those performed at the clavicles, at the
cervicothoracic transition and at the axillary cavum. Another
factor that may have contributed to our recurrence rate was
a higher prevalence of GII (72.7%) and GIII (18.2%) tumors,
which have been correlated with worse prognoses.5,8
We prefer Marlex mesh when bone stabilization is
required, and it was used in 90.9% of our patients.
Gonfiotti et al.9 used a prosthetic material in 71% of 41
patients, primarily a 2-mm expanded polytetrafluoroethy-
lene (ePTFE) patch. This material has additional features,
such as two antimicrobial preservative agents, a smooth
visceral surface to minimize adhesions, and a textured
external surface for tissue in-growth, which result in its
higher cost. We advocate the use of plain Marlex mesh
because no complications were observed in this series.
Muscle flaps were used in 5 of the patients (45.4%) in close
interaction with the plastic surgery team, which is similar to
the rates reported by other studies (12.5 to 29.3%).3,9
The treatment goal for chest wall chondrosarcomas must
initially be surgical resection, regardless of the size or
histological grade of the tumor, as long as it is resectable.1-5
In this context, the best result is obtained when the resection
includes 4-cm margins.5 There are no known factors that can
influence the manifestation of chondrosarcomas in sites
unfavorable to resection; however, early detection can
reduce the occurrence of unresectable cases.1-5
CONCLUSIONS
Despite the limited sample size, higher recurrence rates
were observed in our study, mainly due to a high incidence
of bulky chondrosarcomas located in anatomically unfavor-
able locations, such as the clavicles, the sternum, the cervi-
cothoracic transition and the axillary cavum.
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